Abstract
Gliadin antibodies of the IgG and IgA isotypes and IgG subclasses were measured in 200 adults who were randomly selected from the Icelandic National Register. Those None of the study subjects had typical features of severe malabsorption. A significantly higher proportion of the gliadin antibody positive participants claimed to have had unexplained attacks of diarrhoea (p=003), however. There was also increased prevalence of chronic fatigue in the IgA-gliadin antibody positive individuals (p=0 0037), but participants with IgG-gliadin antibodies did not report this complaint more often than the gliadin antibody negative controls. The overall prevalence of skin problems was not increased in the gliadin antibody positive participants. Two of the gliadin antibodies positive subjects, however, had history of pruritic vesicular skin eruptions on extensor sites. They had both been treated by dermatologists and did not have any skin eruptions at the time of the study. Skin biopsies were not carried out. Nine of the study subjects, seven of whom were gliadin antibody positive, complained of chronic or recurrent headaches. Four had classical migraine and they were all gliadin antibody positive. None of the other recorded complaints were more common in the gliadin antibody positive group.
As shown in Table I Measurements at an interval of three years showed that the levels and patterns of these antibodies were remarkably stable in the study subjects. As our original study group 4 We know of only one attempt to study the incidence of gluten sensitive enteropathy using measurement of gliadin antibodies in serum as a screening procedure."' Sera from 1866 blood donors were tested and all those above the 3% limit for IgA gliadin antibodies were offered jejunal biopsy. Of 43 who underwent this examination seven had mucosal changes consistent with gluten sensitive enteropathy, suggesting a prevalence of 3-7 per 1000 in apparently 
